| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$151 |
Update - Notification of buy-back - VVA
|
13 Apr 2026 9:07AM |
$1.550 |
$1.530 |
fallen by
1.29%
|
|
| Kingsrose Mining Limited (KRM) ORDINARY FULLY PAID |
Materials |
$20 |
Kingsrose Provides Permitting Update for its Penikat Project
|
13 Apr 2026 9:07AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$25 |
Update - Notification of buy-back - KME
|
13 Apr 2026 9:06AM |
$0.545 |
$0.480 |
fallen by
11.93%
|
|
| Vista Group International Limited (VGL) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$486 |
VGL - Governance Roadshow
|
13 Apr 2026 9:05AM |
$1.500 |
$2.030 |
risen by
35.33%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$22,161 |
PME signs 5-year, A$37M contract renewal with Northwestern
|
13 Apr 2026 9:04AM |
$126.920 |
$212.130 |
risen by
67.14%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- PME signs 5-year, A$37M contract renewal for Visage 7 Viewer
- Transaction-based renewal contract with potential upside
- Renewal includes increased minimums and fee per transaction
- Northwestern Medicine is a premier academic health system
- Pro Medicus has contracted nearly $80 million in renewals recently
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,473 |
SX2 FY26 Third Quarter Financials and Management Analysis
|
13 Apr 2026 9:04AM |
$10.000 |
$9.180 |
fallen by
8.20%
|
|
SX2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss decreased to $591,021 for Q3 2026 from $2,434,164 in Q3 2025.
- Interest income increased significantly from $12,016 in Q3 2025 to $1,043,768 in Q3 2026.
- Corporate restructuring costs recognized in the prior period were $613,577 in Q3 2025.
- Total cash and cash equivalents at the end of February 2026 were $123.2 million.
- The company has no defaults or arrears on debt or lease payments.
- Exploration and evaluation costs for the nine months ended February 28, 2026, were $16,721,924.
- The cash runway is projected to fund operations through resource establishment and PEA completion by mid-2027.
- The company has sufficient cash to fund operations without any debt obligations.
- Southern Cross Gold Consolidated Ltd. listed on ASX under the symbol SX2.
- A private placement in May 2025 raised gross proceeds of $143 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stavely Minerals Limited (SVY) ORDINARY FULLY PAID |
Materials |
$18 |
Proposed issue of securities - SVY
|
13 Apr 2026 9:04AM |
$0.014 |
$0.017 |
risen by
21.43%
|
|
| Stavely Minerals Limited (SVY) ORDINARY FULLY PAID |
Materials |
$18 |
$4.0 MILLION PLACEMENT
|
13 Apr 2026 9:04AM |
$0.014 |
$0.017 |
risen by
21.43%
|
|
SVY - Price-sensitive ASX Announcement
Full Release
Key Points
- Stavely Minerals Limited has received commitments for a $4.0 million placement.
- The placement price is set at $0.0115 per share, representing discounts compared to recent trading prices.
- The placement proceeds will fund the Thursday’s Gossan Scoping Study, pre-feasibility works, and exploration targeting.
- Director Peter Ironside's loan facility will be partially converted into shares as part of the placement.
- GBA Capital and Peak Asset Management are the Joint Lead Managers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$139 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
13 Apr 2026 9:04AM |
$1.555 |
$1.500 |
fallen by
3.54%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- EMVision is advancing its Pivotal (Validation) Trial for FDA De Novo clearance.
- Eight hospitals are actively recruiting for the trial with no device-related adverse events reported.
- EMVision's technology featured at the NABI Conference in Texas and in a forthcoming US academic paper.
- Pre-hospital feasibility studies for the First Responder device are nearing completion.
- Cash reserves of $18.4 million as of 31 March 2026, with additional grant funding available.
- Received $3.8 million R&D tax refund for FY25.
- Significant grant support from Australian Stroke Alliance and CRC-P Program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$137 |
Maronan Project Drilling Restarts With Second Rig Secured
|
13 Apr 2026 9:03AM |
$0.330 |
$0.435 |
risen by
31.82%
|
|
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$36 |
Murga Scandium MRE increases by 300%
|
13 Apr 2026 9:03AM |
$0.014 |
$0.013 |
fallen by
7.14%
|
|
RIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Murga Scandium MRE increased by 300%
- Inferred mineral resource: 56.1Mt @ 138ppm Sc
- Resource equates to 7,760t Sc and 11,900t Sc Oxide
- Potential for further expansion and upgrade
- Exploration drilling and metallurgical work planned
- Low iron content allows for cost-effective extraction
- Rimfire is a significant scandium resource holder in the Fifield area
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carlton Investments Limited (CIN) ORDINARY FULLY PAID |
Financials |
$887 |
Update - Notification of buy-back - CIN
|
13 Apr 2026 9:01AM |
$35.000 |
$33.690 |
fallen by
3.74%
|
|
| Sandon Capital Investments Limited (SNC) ORDINARY FULLY PAID |
Financials |
$111 |
Chairman's Letter
|
13 Apr 2026 9:01AM |
$0.780 |
$0.715 |
fallen by
8.33%
|
|
| Prairie Lithium Limited (PL9) ORDINARY FULLY PAID |
Materials |
$36 |
Clear Path to First Revenue
|
13 Apr 2026 9:00AM |
$0.006 |
$0.007 |
risen by
8.33%
|
|
PL9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Prairie Lithium Limited is nearing completion of its Direct Lithium Extraction (DLE) facility, with first production targeted for Q4 2026.
- The company has secured a binding offtake agreement with Hydro Lithium for 100% of its Phase 1 production, which will produce 150 TPA LCE.
- Hydro Lithium will also provide approximately $10 million in refining equipment, reducing Prairie Lithium's capital needs.
- The project is strategically located in Saskatchewan, Canada, which is favorable for mining and has existing infrastructure.
- Prairie Lithium aims to expand further by leveraging a 4.6 million tonne LCE resource base and replicating production across multiple pads.
- The project's development is supported by strong governmental backing from both Canada and South Korea.
- The scalable development model provides a clear pathway to substantial long-term supply growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aland Equity Group Limited (AEG) ORDINARY FULLY PAID |
Financials |
$65 |
Market Update
|
13 Apr 2026 9:00AM |
$0.034 |
$0.088 |
risen by
158.82%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$8 |
Completion of CannPal Asset Acquisition and Neuvis Option
|
13 Apr 2026 8:58AM |
$0.033 |
$0.068 |
risen by
106.06%
|
|
| Vmoto Limited (VMT) ORDINARY FULLY PAID |
Consumer Discretionary |
$46 |
Notification of cessation of securities - VMT
|
13 Apr 2026 8:58AM |
$0.091 |
$0.115 |
risen by
26.37%
|
|
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$60 |
Sale of CFS to DRX/Sibelco Silica J/V
|
13 Apr 2026 8:57AM |
$0.017 |
$0.012 |
fallen by
29.41%
|
|
DRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Diatreme sells Cape Flattery Silica Project to Cape Silica Holdings.
- Transaction valued at $26.01 million.
- Diatreme to be reimbursed $2.1 million.
- Generates $7.4 million in additional funding.
- Sibelco contributes up to $9.5 million.
- Shareholder approval required.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,306 |
Record Cash Balance and FY26 Guidance Maintained
|
13 Apr 2026 8:55AM |
$5.220 |
$4.910 |
fallen by
5.94%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsgate Consolidated Limited produced 21,036 ounces of gold and 182,549 ounces of silver in the March 2026 quarter.
- This marked the fifth consecutive quarter of over 20,000 ounces of gold production.
- Total production for FY26 so far includes 65,915 ounces of gold and 545,932 ounces of silver.
- As of 31 March 2026, the total cash, bullion, and doré amounted to A$213 million, a 19% increase from the December 2025 quarter.
- A new 6030 excavator was added to the fleet, supporting new monthly records in material movement at Chatree.
- An interim dividend of approximately A$26 million was paid on 10 April 2026.
- The company remains on track to achieve FY26 guidance and is focused on a strong final quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sandon Capital Investments Limited (SNC) ORDINARY FULLY PAID |
Financials |
$111 |
Cleansing Notice
|
13 Apr 2026 8:54AM |
$0.780 |
$0.715 |
fallen by
8.33%
|
|
| Treasury Wine Estates Limited (TWE) ORDINARY FULLY PAID |
Consumer Staple |
$3,642 |
Renewal of consultancy agreements with Leslie and Rich Frank
|
13 Apr 2026 8:54AM |
$3.980 |
$4.510 |
risen by
13.32%
|
|
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$31 |
Update - Notification of buy-back - EPY
|
13 Apr 2026 8:54AM |
$0.160 |
$0.125 |
fallen by
21.88%
|
|
| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$275 |
Revised NBIO to acquire MVF
|
13 Apr 2026 8:53AM |
$0.665 |
$0.705 |
risen by
6.02%
|
|
MVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Revised non-binding indicative proposal to acquire Monash IVF.
- Offer price set at $0.90 per share.
- Conditions include exclusive due diligence and no fiduciary exceptions.
- Monash IVF board must unanimously recommend the proposal.
- Proposal is valid until 21 April 2026.
- Consortium holds 19.6% of Monash IVF shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BMC Minerals Ltd. (BMC) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$714 |
BMC Receives Positive Decision Document for the KZK Project
|
13 Apr 2026 8:53AM |
$2.500 |
$2.600 |
risen by
4%
|
|
BMC - Price-sensitive ASX Announcement
Full Release
Key Points
- BMC Minerals Ltd. received a positive Decision Document for the KZK Project in the Yukon, Canada.
- The Decision Document was issued by Yukon and Canadian government bodies after approval by the YESAB in 2020.
- The document includes 52 terms and conditions, with 10 new terms focusing on areas like financial oversight and operational performance.
- BMC is progressing with permit applications to develop the ABM Mine, targeting a Final Investment Decision by late 2027.
- The KZK Project includes the ABM deposit and copper-rich Kona deposit, hosting significant mineral resources.
- BMC's feasibility study revealed a pre-tax NPV of US$835 million with a payback period of 2 years.
- The project plans to produce three concentrates: high precious metals, copper, and zinc.
- 95% of the first five years of production has secured binding offtake agreements.
- BMC aims to deliver sustainable benefits to the Kaska First Nations and value to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vulcan Energy Resources Limited (VUL) ORDINARY FULLY PAID |
Materials |
$1,412 |
German State grants royalty exemption for lithium production
|
13 Apr 2026 8:52AM |
$3.720 |
$2.950 |
fallen by
20.70%
|
|
VUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Germany's Rhineland-Palatinate state grants a royalty exemption for lithium production for five years until December 2030.
- The exemption is intended to secure lithium supply until sufficient domestic capacities are established.
- Vulcan Energy's Lionheart Project in Rhineland-Palatinate will benefit from this exemption.
- The exemption aligns with Germany's strategic goals and the European Union's Critical Raw Materials Act.
- The Lionheart Project aims to produce 24,000 tonnes of lithium hydroxide monohydrate annually.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
